Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | United States | $20.37M | 64,450,385 | 35.53% | 64.47% | Net Buying | Net Buying |
| INTZ | INTRUSION INC | United States | $3.11M | 1,944,675 | 8.92% | 91.08% | Net Buying | Net Buying |
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $7.46M | 439,926,480 | 0.79% | 0.00% | ||
| LYRA | LYRA THERAPEUTICS INC | United States | $31.76M | 60,964,859 | 69.46% | 14.19% | Net Buying | |
| PPBT | PURPLE BIOTECH LTD | Israel | $10.42M | 198,386,080 | 1.23% | 0.00% | ||
| IQ | IQIYI INC | China | $4.94B | 6,716,137,085 | 4.53% | 0.00% | ||
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $7.46M | 35,538,034 | 5.35% | 49.17% | Net Selling | Net Buying |
| LIFE | ATYR PHARMA INC | United States | $114.56M | 69,010,940 | 59.74% | 22.13% | Net Buying | |
| GOEV | CANOO INC | United States | $169.36M | 64,397,326 | 44.63% | 55.37% | Net Buying | |
| BPTH | BIO-PATH HOLDINGS INC | United States | $1.84M | 678,795 | 3.24% | 96.76% | ||
| CLNN | CLENE INC | United States | $54.45M | 128,430,098 | 9.06% | 52.69% | Net Buying | Net Selling |
| APLM | APOLLOMICS INC | United States | $37.59M | 89,495,790 | 9.89% | 0.00% | ||
| KZR | KEZAR LIFE SCIENCES INC | United States | $59.33M | 72,801,359 | 67.83% | 21.82% | Net Buying | |
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.02M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| BIOL | BIOLASE INC | United States | $5.76M | 32,522,593 | 0.92% | 56.96% | ||
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $58.17M | 35,686,279 | 13.69% | 8.02% | Net Selling | Net Selling |
| BNED | BARNES & NOBLE EDUCATION INC | United States | $12.23M | 53,156,369 | 22.27% | 77.73% | Net Selling | |
| GOSS | GOSSAMER BIO INC | United States | $176.18M | 225,582,250 | 86.47% | 13.53% | Net Buying | Net Selling |
| YTEN | YIELD10 BIOSCIENCE INC | United States | $3.30M | 641,738 | 2.09% | 97.91% | Net Buying | Net Buying |
| MVST | MICROVAST HOLDINGS INC | United States | $137.03M | 317,206,095 | 20.63% | 31.20% | Net Selling | |
| AADI | AADI BIOSCIENCE INC | United States | $49.11M | 24,554,205 | 26.93% | 73.07% | Net Selling | Net Selling |
| AGEN | AGENUS INC | United States | $271.25M | 20,946,004 | 63.15% | 36.85% | Net Buying | Net Buying |
| OCUP | OCUPHIRE PHARMA INC | United States | $49.87M | 24,813,370 | 1.23% | 98.77% | Net Buying | Net Buying |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.71M | 3,069,516 | 1.86% | 98.14% | Net Buying | |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $31.42M | 39,272,434 | 3.63% | 96.37% | Net Buying | Net Selling |
| TARA | PROTARA THERAPEUTICS INC | United States | $59.71M | 20,589,976 | 11.95% | 88.05% | Net Selling | |
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $80.87M | 54,642,580 | 81.93% | 18.07% | Net Buying | Net Buying |
| INAB | IN8BIO INC | United States | $43.20M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $92.48M | 53,149,778 | 33.44% | 24.16% | ||
| NTBL | NOTABLE LABS LTD | Israel | $8.48M | 9,018,261 | 2.63% | 97.37% | Net Selling | |
| LUXH | LUXURBAN HOTELS INC | United States | $34.58M | 41,814,361 | 7.28% | 85.94% | Net Buying | |
| EVA | ENVIVA INC | United States | $39.71M | 74,496,537 | 27.69% | 72.31% | Net Selling | Net Selling |
| SYBX | SYNLOGIC INC | United States | $21.43M | 11,646,977 | 3.98% | 96.02% | Net Selling | Net Selling |
| FEMY | FEMASYS INC | United States | $29.83M | 22,099,347 | 6.42% | 8.05% | ||
| GEVO | GEVO INC | United States | $165.13M | 236,232,717 | 35.74% | 11.14% | Net Selling | |
| IMRX | IMMUNEERING CORP | United States | $48.32M | 29,283,272 | 53.75% | 46.25% | Net Selling | Net Selling |
| GNLX | GENELUX CORP | United States | $103.16M | 26,865,473 | 21.54% | 5.21% | Net Selling | Net Selling |
| PRST | PRESTO AUTOMATION INC | United States | $13.65M | 80,791,967 | 8.56% | 68.69% | Net Buying | |
| DDC | DDC ENTERPRISE LTD | China | N/A | 20,158,176 | 0.21% | 0.00% | ||
| VOR | VOR BIOPHARMA INC | United States | $119.30M | 68,168,771 | 87.43% | 10.18% | Net Selling | Net Selling |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $136.59M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $12.12M | 284,094,700 | 0.99% | 5.96% | ||
| LUMO | LUMOS PHARMA INC | United States | $24.32M | 8,107,121 | 17.70% | 82.30% | Net Buying | Net Buying |
| IKNA | IKENA ONCOLOGY INC | United States | $63.22M | 48,258,111 | 66.60% | 18.22% | ||
| SPRB | SPRUCE BIOSCIENCES INC | United States | $31.03M | 41,149,160 | 63.59% | 36.41% | Net Selling | Net Selling |
| FBIO | FORTRESS BIOTECH INC | United States | $34.24M | 19,234,526 | 24.35% | 62.68% | Net Buying | Net Buying |
| CVKD | CADRENAL THERAPEUTICS INC | United States | $8.00M | 16,008,469 | 3.45% | 46.72% | Net Buying | |
| PGEN | PRECIGEN INC | United States | $358.44M | 248,919,096 | 25.15% | 73.45% | Net Buying | Net Selling |
| MBRX | MOLECULIN BIOTECH INC | United States | $11.23M | 2,227,516 | 45.78% | 54.22% | Net Buying | |
| PASG | PASSAGE BIO INC | United States | $78.39M | 55,598,796 | 43.60% | 56.40% | Net Buying | Net Selling |
| ACET | ADICET BIO INC | United States | $138.84M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| TPST | TEMPEST THERAPEUTICS INC | United States | $82.78M | 22,192,026 | 4.15% | 95.85% | ||
| SGMO | SANGAMO THERAPEUTICS INC | United States | $94.10M | 178,906,350 | 48.59% | 17.99% | Net Selling | Net Selling |
| IVA | INVENTIVA SA | France | $178.76M | 52,115,807 | 9.33% | 0.00% | ||
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $147.93M | 202,645,716 | 46.82% | 14.34% | Net Selling | Net Buying |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $553.00M | 64,227,371 | 35.78% | 53.45% | Net Selling | Net Selling |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $110.61M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $82.08M | 27,918,560 | 18.78% | 38.25% | ||
| GRTS | GRITSTONE BIO INC | United States | $94.34M | 98,065,594 | 42.92% | 22.25% | Net Buying | |
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $107.43M | 32,260,510 | 26.67% | 12.70% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.